Panobinostat in Combination With Idarubicin and Cytarabine in Patients Aged 65 Years or Older With Newly Diagnosed Acute Myeloblastic Leukaemia (AML)
Clinical trial NCT00840346 · COMPLETED
Trial details
- NCT number
- NCT00840346
- Sponsor
- PETHEMA Foundation
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-01
- Primary completion
- 2016-05-01
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.